Session Details

Fibrinogen Factor XIII and Thrombin Poster Session

Tuesday, 23 March 2004 17:20 -18:30

The Viscosity of Fibrinogen Subfractions and of Edta Denatured Fibrinogen do not Differ from that of Native Fibrinogen
  • MD Torstein Jensen, Ullevaal University Hospital, Norway
  • Mesangial Tissue Factor and Factor V Expressions Promote Intramesangial Coagulation and ECM Accumulation in a Rat Model of Glomerulonephritis
  • Ning Liu, Graduate School of Medicine, Kyoto University, Japan
  • Effect of Ca2+ Bound to Haemostats on Certain Platelet Functions
  • Miroslav Pecka, Charles University, Czech Republic
  • Jaroslav Maly, Charles University, Czech Republic
  • Study on the Preeclampsia-like Change in Pregnant Mice Induced by Phosphatidylserine/phosphatidylcholine Microvesicles (PSPC)
  • Takao Kobayashi, Shinshu University School of Health Sciences, Japan
  • Streptokinase-induced Arterial Re-canalization is Hindered by Heparin in a Rabbit Model
  • Dr Michal Vlasin, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
  • From One to Thousands: The Modulation of the Protofibrils Number Per Fiber Section
  • Prof Marco De Spirito, Institute of Physics, Catholic University S. Heart, Rome, Italy
  • A Simplified Test of Fibrin Generation and Lysis Shows a Poor Correlation with the International Normalised Ratio (INR) in Patients on Warfarin
  • Marie-Christine J Morel-Kopp, Northern Blood Research Centre, Australia
  • Detection of Four Novel Mutations in a Genetic Study of Fibrinogen Disorders in a UK Population
  • Marian Hill, Queens Medical Centre, Nottingham, United Kingdom
  • The Correlation of Plasma Fibrinogen Level with Relevant Variables in a Clinical Intervension Trial
  • Christa J Grobler, Vaal Triangle Technikon, South Africa
  • Inhibition of Smooth Muscle Cell Migration by Eptifibatide in Vitro. Eptifibatide Inhibits Localization of Integrin αν-subunit to focal adhesions.
  • Juergen F Froehlich, University of Vienna, Austria
  • Fibrinogen Córdoba I: A Heterozygous Dysfibrinogenemia (gamma Arg 275 --> Hys) with Bleeding Tendency
  • MSc Hugo A Guglielmone, Universidad Nacional De Cordoba, Argentina
  • Inhibitors of the Clotting Factors XIa, XIIa and Plasma Kallikrein Participating in the Early Steps of the Intrinsic Coagulation Cascade
  • Dr Joerg Stuerzebecher, University of Jena, Germany
  • Highly Potent Inhibitors of Coagulation Factor Xa with Improved Pharmacokinetics
  • Dr Joerg Stuerzebecher, University of Jena, Germany
  • Protein Characterization of Recombinant Human Thrombin and Demonstration of Efficacy in Models of Surgical Bleeding
  • Paul D Bishop, ZymoGenetics, Inc, United States
  • Human Bb Fibrinogen Interacts with the ORF3 Protein of Hepatitis E Virus
  • Sunil K Lal, International Centre for Genetic Engineering & Biotechnology, India
  • Aspirin Modifies the Effect of Factor XIII Val34Leu Polymorphism on Fibrin Structure
  • Jan Brozek, Jagiellonian University School of Medicine, Poland